Ironwood Pharmaceuticals | IRWD - Pre Tax Profit

Stock Price
4.56
Daily Change
0.11 2.47%
Monthly
11.76%
Yearly
168.24%
Q1 Forecast
4.74

Ironwood Pharmaceuticals reported $68.02M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Amarin USD -8.12M 5.34M Sep/2025
Ardelyx USD -867K 18.21M Sep/2025
Astellas Pharma JPY 133.96B 29.77B Dec/2025
AstraZeneca USD 3.24B 117M Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Exact Sciences USD -17.76M 17.7M Sep/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Incyte USD 482.31M 75.7M Sep/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Moderna USD -187M 631M Sep/2025
Myriad Genetics USD 6.2M 2.1M Dec/2024
Pacira USD -1.93M 10.63M Jun/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Takeda JPY 133.86B 105.69B Dec/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025